Cannabinoids
Last published: December 15, 2025
What are cannabinoids?
Cannabinoids include any drug that acts on the cannabinoid receptors in the body’s endocannabinoid system, and any natural or synthetic (lab-produced) drug that is made from, or related to, the cannabis plant.1
There are also cannabinoids that are naturally made in the body, these are called endogenous ligands, but are more commonly known as endocannabinoids.2
The endocannabinoid system helps to regulate many functions, including the immune system, mood and emotions, memory, sleep and appetite.2,3
Commonly used cannabinoids
Explore cannabinoids on the Drug Wheel
What do cannabinoids look like?
Cannabinoids come in many different forms, including:
- cannabis leaves and flowers (buds)
- ground plant material sprayed with chemicals in brightly coloured packaging (synthetic cannabinoids)
- capsules and pills
- foods, also known as edibles (gummies, brownies, etc.)
- skin patches, creams and lotions
- oils
- mouth sprays
- tinctures.4
Other names for cannabinoids
There are many other names for cannabis, these include marijuana, yarndi, pot, weed, hash, dope, gunja, joint, stick, chronic, cone, chuff, mull, 420, 710, dabs, dabbing, BHO.
‘Novel’ synthetic cannabinoids are marketed under different names. Spice was one of the earliest and more common terms. Other names have emerged including Kronic, Northern Lights, K2 and Kaos.
Types of cannabinoids
Natural (phytocannabinoids)
Cannabis plants produce hundreds of phytocannabinoids, with at least 120 being identified to date.5
The most well-known are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).5
THC is the main cannabinoid responsible for the psychoactive (‘high’) effects of cannabis.
CBD has many potential medicinal benefits and may lessen the intensity of the psychoactive effects from THC.5
Other cannabinoids found in cannabis include:
- Cannabigerol (CBG), works with THC and CBD to balance effects on the nervous system and lessens the effects of THC
- Cannabinol (CBN), slightly psychoactive; lessens effects of THC
- Cannabichromene (CBC), similar in chemical structure to THC, but is not known to be psychoactive
- Tetrahydrocannabivarin (THCV).5
Novel synthetic and semi-synthetic cannabinoids
There are also synthetic and semi-synthetic cannabinoids, also known as ‘novel cannabinoids’ found in the illegal market.
Novel synthetic cannabinoids are designed to mimic the effects of THC but often produce more potent and unpredictable effects. They often come in brightly coloured packaging or are incorrectly sold as cannabis.6 Examples include: AB-CHMINACA, JWH-018, UR-144.
Novel semi-synthetic cannabinoids are made from plant-based cannabinoids being altered in a lab. Examples include: Hexahydrocannabinol (HHC), Delta-8-THC, and Delta-10-THC.7
Both can produce more potent and unpredictable effects.
Medical cannabinoid products
Therapeutic Goods Administration (TGA) approved medical cannabinoid products are available in Australia with a prescription. They include brand name products Sativex® and Eipdyolex®.4
Other plant-based cannabinoid products, not tested for quality and safety by the TGA, are available through the Special Access Scheme (SAS) under different brand names.8
There are also prescribed synthetic and semi-synthetic medical cannabinoid products, which have been tested for quality and safety, unlike novel synthetic cannabinoids.4 They are usually designed with the aim to have similar effects to THC or CBD. None of these products are approved for use in Australia, but they are prescribed in some countries internationally. Examples include Marinol®, Syndros® and Cesamet®.
How are they used?
Cannabinoids are most often smoked, eaten/swallowed or vaporised.9
Medicinal cannabis is prescribed to relieve the symptoms of chronic or cancer-related pain, multiple sclerosis (MS), epilepsy, Tourette syndrome, and a range of other health conditions.4 THC for medical use is taken in many ways, including:
- vaporised
- eaten
- dissolved under the tongue (sub-lingual)
- mouth sprays
- suppositories
- applied onto the skin.10
Smoking cannabinoids for medicinal reasons is not recommended, as it’s harder to accurately dose and the harms to your body from smoking can be worse than the benefits experienced from the cannabinoids.11
Effects of cannabinoids
The use of any drug can have risks. It’s important to be careful when taking any type of drug.
Cannabinoids affect everyone differently, based on:
- size, weight and health
- whether the person is used to taking it
- whether other drugs are taken around the same time
- the amount taken
- the strength of the drug (varies from batch to batch)
- the environment (where the drug is taken).
Onset and duration of effects
How fast a drug takes effect and how long it lasts can vary depending on how it's taken - for example, whether it's smoked or swallowed.12
Effects
Learn more about the effects of a specific cannabinoid:
Effects can include:
- feeling happy or excited
- feeling relaxed or calm
- anxiety, paranoia or panic
- dry mouth
- loss of motivation
- impaired memory/concentration
- bloodshot eyes
- dizziness
- increased heart rate
- increased body temperature
- nausea
- seizures.13
Impact of mood and environment
Drugs that affect a person’s mental state (psychoactive drugs) can also have varied effects depending on a person’s mood (often called the ‘set’) or the environment they are in (the ‘setting’):
- Set: a person’s state of mind, previous encounters with the drug, and expectations of what’s going to happen. For example, feelings of stress or anxiety before using certain cannabinoids, like THC, may result in an unpleasant experience and make those feelings worse.
- Setting: the physical and social environment where you take cannabinoids– whether it’s known and familiar, who you're with, if you're indoors or outdoors, the type of music or sounds, and lighting. The ideal setting to take cannabinoids will vary based on the individual and what they’re using. For example, one person might enjoy cannabinoids in a loud social setting like a party, while another may prefer a quieter place with close friends.14
Being in a good state of mind, with trusted friends and a safe environment before taking cannabinoids reduces the risk of having a bad experience.14
Overdose
There have been no recorded deaths from THC or CBD overdose in Australia.15, 16
But synthetic cannabinoid overdose can cause death.17 And, sometimes people take synthetic cannabinoids without knowing, thinking they’re using cannabis (THC).
Call triple zero (000) and request an ambulance if you, or someone else, has any of the following symptoms (emergency services are there to help and can provide instructions over the phone):
- chest pain or discomfort that may feel like pressure, squeezing, heaviness, or burning. It may also be felt in the arm, shoulder, back, neck, or jaw
- irregular heartbeat
- breathing difficulties
- hallucinations, paranoia.18
Mixing cannabinoids and other drugs
Mixing cannabinoids with other drugs can have unpredictable effects and increase the risk of harm. Mixing means using more than one drug (including alcohol or medications) at the same time, or one after another. You should also consider what drugs you’ve taken in the last 24 hours.
Using more than one drug or type of drug at the same time is also called polydrug use.19
More on Polydrug use
Polydrug use is a term for the use of more than one drug or type of drug at the same time or one after another. Polydrug use can involve both illicit drugs and legal substances, such as alcohol and medications.
Reducing harm
There are ways you can reduce the risk of harm when using cannabinoids:
- Start low, go slow - try a little bit first, to see how you feel:
- if you have eaten/swallowed cannabis, wait at least 4 hours before deciding whether to take more
- if you have used cannabis any other way, wait at least 30 minutes.
- Avoid novel synthetic cannabinoids - due to their unpredictable effects. These drugs often come in brightly coloured packages with the flower or plant material pre-chopped or powdered.
- Choose ‘full spectrum’ products with a balance of other cannabinoids like CBD, rather than THC only products - this may help reduce the risk of negative side effects and prevent worsening symptoms of mental health conditions, like schizophrenia and psychosis.20, 21
- If affected by cannabinoids, don’t drive, operate heavy machinery or do any other potentially risky activities, such as swimming - as cannabis slows response times and affects coordination and balance.4
- Take less or avoid using THC or synthetic cannabinoids entirely if you:
- are a young person (25 and under), as young people can experience additional negative effects
- have experienced, or have a family history of, schizophrenia or bipolar disorder
- have an existing heart condition, as they can put extra strain on your heart. It’s especially important to avoid taking stimulants if you have a heart condition and choose to take cannabis.4
If smoking or vaping:
- avoid using tobacco as a mixer
- clean smoking equipment regularly, including mouthpiece and any water containing parts to avoid mould or bacterial growth
- avoid smoking out of plastic bottles or aluminium cans due to toxic fumes
- use edibles, oils, or a vape instead of smoking to avoid harmful smoke and chemicals.22
Pregnancy, breastfeeding and cannabinoids
We know that the endocannabinoid system plays an important role in reproduction and pregnancy.23 And that most cannabinoids likely pass through breastmilk into the newborn baby.24
Because of this, it’s recommended not to use cannabinoids if pregnant or breastfeeding.
Getting help
If your use of cannabinoids is affecting your health, family, relationships, work, school, financial or other life situations, or you’re concerned about someone you care about, there is help and support.
- Call the National Alcohol and Other Drug Hotline on 1800 250 015 for free and confidential advice, information and counselling about alcohol and other drugs
- Search our Help and Support database directly to find your preferred support, by adding your location or postcode and filtering by service type.
Path2Help
Not sure what you are looking for? Try our intuitive Path2Help tool and be matched with support information and services tailored to you.
Find out more
The use of cannabinoids – both synthetic and plant-based - is illegal in most of Australia. Personal use, possession, production, growing and selling of cannabinoids or the equipment used to consume cannabinoids (bongs or pipes) can lead to fines and/or imprisonment.
For cannabis, decriminalisation is practised in some form across Australia, meaning those caught with cannabis or cannabis equipment may receive a warning, fine, or be referred to education or treatment, instead of imprisonment. In the ACT, people 18 years old and over can have up to 50 grams of dried cannabis and grow two plants each (maximum of four per household) for personal use. Selling or sharing cannabis is still illegal.
Cannabis for medical or scientific use is also legal under federal law. Patients need a prescription from an authorised doctor and usually apply through the TGA’s Special Access Scheme. Rules for access can be different across states and territories. Speak to your doctor about using medical cannabis if you believe it may be the right treatment for you.
Despite attempts to sell and market novel synthetic cannabinoids as a ‘legal’ alternative to cannabis, they are illegal. States/territories have continued to change their laws to ensure these products remain illegal.
In 2025 the current laws are:
- In Queensland, New South Wales, South Australia and Victoria there’s a ‘blanket ban’ on possessing or selling any substance with a psychoactive effect, other than alcohol, tobacco, and foodstuffs such as caffeine.
- In Western Australia, specific New and Emerging Substances (NPS) substances are banned, and new ones are regularly added to the banned list. This means a drug that was legal to sell or possess today, may be illegal tomorrow.
- Commonwealth laws ban any other psychoactive drug that isn’t already banned by existing laws in states and territories.25, 26
See also, drugs and the law.
- Mertz LA, Culvert LL. Cannabinoids. Farmington Hills, MI: Gale; 2020 [12.09.2025].
- Kendall DA, Yudowski GA. Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease. Frontiers in Cellular Neuroscience [Internet]. 2017 [12.09.2025]; 10p.].
- Cannabinoids. Detroit, MI: Macmillan Reference USA; 2009 [03.09.2025].
- Therapeutic Goods Administration. Medicinal cannabis: Information for patients. 2025 [27.10.2025].
- Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in pharmacology [Internet]. 2021 [20.11.2025]; 12:[777804 p.].
- Advisory Council on the Misuse of Drugs. Synthetic cannabinoid receptor agonists (SCRA). [Internet]. 2025 [20.11.2025]:[48 p.].
- Advisory Council on the Misuse of Drugs. 'Semi-synthetic' Cannabinoids: Cannabinoids related to tetrahydrocannabinol and cannabidiol. [Internet]. 2025 [20.11.2025]:[48 p.].
- Therapeutic Goods Administration. Medicinal cannabis product list. 2025 [27.10.2025].
- Sutherland R, Karlsson A, Uporova J, Palmer L, Tayeb H, Chrzanowska A, et al. Australian Drug Trends 2025: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. [Internet]. 2025 [27.10.2025]:[141 p.].
- Therapeutic Goods Administration. Guidance for the use of medicinal cannabis in Australia: Products. 2025 [27.10.2025].
- Therapeutic Goods Administration. Guidance for the use of medicinal cannabis in Australia: Overview. 2025 [27.10.2025].
- Gruenert M, Campbell S, Tsantefski L. Working with substance-affected parents and their children: a guide for human service workers. [S.l.]: ROUTLEDGE; 2021 [02.12.2025].
- Adley M, Jones G, Linnell M. The Drugs Wheel. [12.12.2025].
- Nutt DJ. Drugs without the hot air : making sense of legal and illegal drugs. Cambridge: UIT Cambridge Ltd.; 2020 [27.10.2025].
- Zahra E, Darke S, Degenhardt L, Campbell G. Rates, characteristics and manner of cannabis-related deaths in Australia 2000-2018. Drug and Alcohol Dependence [Internet]. 2020 [29.04.2025]; 212:[108028 p.].
- Rock KL, Englund A, Morley S, Rice K, Copeland CS. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020). Journal of Psychopharmacology (Oxford, England) [Internet]. 2022 [12.09.2025]; 36(12):[1362–70 p.].
- Darke S, Duflou J, Farrell M, Peacock A, Lappin J. Characteristics and circumstances of synthetic cannabinoid-related death. Clinical Toxicology [Internet]. 2020 [12.09.2025]; 58(5):[368–74 p.].
- Cohen K, Weinstein AM. Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective. Frontiers in public health [Internet]. 2018 [27.10.2025]; 6:[162 p.].
- Darke S, Lappin J, Farrell M. The clinician's guide to illicit drugs and health: Silverback Publishing; 2019 [12.09.2025].
- Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of psychopharmacology (Oxford, England) [Internet]. 2013 [12.09.2025]; 27(1):[19–27 p.].
- Schubart CD, Sommer IEC, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MPM. Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophrenia Research [Internet]. 2011 [12.09.2025]; 130(1-3):[216–21 p.].
- Queensland Injectors Health Network Queensland Injectors Voice for Advocacy and Action. Cannabis. n.d. [12.09.2025].
- Ezechukwu HC, Diya CA, Shrestha N, Hryciw DH. Role for endocannabinoids in early pregnancy: recent advances and the effects of cannabis use. American journal of physiology, endocrinology and metabolism [Internet]. 2020 [02.12.2025]; 319(3):[E557–E61 p.].
- National Institute of Child Health and Human Development. Drugs and Lactation Database (LactMed®): Cannabidiol. 2025 [02.12.2025].
- National Drug & Alcohol Research Centre (NDARC). New (and emerging) Psychoactive Substances (NPS): NDARC fact sheet. [Internet]. 2016 [02.12.2025]:[3 p.].
- Victorian Department of Health. Synthetic cannabinoids. 2021 [12.03.2025].